Curis Inc financial data

Symbol
CRIS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
128 Spring Street, Building C, Suite 500, Lexington, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 324 % -60.9%
Debt-to-equity 382 % +157%
Return On Equity -328 % -181%
Return On Assets -68 % -45%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.98M shares -94.9%
Common Stock, Shares, Outstanding 5.9M shares -94.1%
Entity Public Float 82.3M USD -8.25%
Common Stock, Value, Issued 59K USD -94.1%
Weighted Average Number of Shares Outstanding, Basic 5.82M shares +20.4%
Weighted Average Number of Shares Outstanding, Diluted 5.82M shares +20.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10.2M USD -0.44%
General and Administrative Expense 19.3M USD +7.97%
Costs and Expenses 59.7M USD +5.13%
Operating Income (Loss) -49.5M USD -6.35%
Nonoperating Income (Expense) 1.98M USD +301%
Net Income (Loss) Attributable to Parent -47.6M USD +1.19%
Earnings Per Share, Basic -8.18 USD/shares +50.9%
Earnings Per Share, Diluted -8.18 USD/shares +50.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10M USD -49.6%
Marketable Securities, Current 18.4M USD -57.9%
Cash, Cash Equivalents, and Short-term Investments 28.4M USD -55.3%
Accounts Receivable, after Allowance for Credit Loss, Current 2.55M USD +6.71%
Assets, Current 34.5M USD -49.1%
Property, Plant and Equipment, Net 308K USD -45.1%
Operating Lease, Right-of-Use Asset 3.75M USD +0.32%
Goodwill 8.98M USD 0%
Other Assets, Noncurrent 3.36K USD
Assets 50.4M USD -40.2%
Accounts Payable, Current 2.45M USD -8.82%
Employee-related Liabilities, Current 1.95M USD -1.81%
Accrued Liabilities, Current 6.74M USD +16.7%
Liabilities, Current 19.4M USD +100%
Operating Lease, Liability, Noncurrent 2.31M USD +6.7%
Liabilities 51.1M USD -12%
Accumulated Other Comprehensive Income (Loss), Net of Tax 42K USD +2000%
Retained Earnings (Accumulated Deficit) -1.22B USD -4.06%
Stockholders' Equity Attributable to Parent -694K USD -103%
Liabilities and Equity 50.4M USD -40.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.2M USD -8.47%
Net Cash Provided by (Used in) Financing Activities -2.41M USD -19.9%
Net Cash Provided by (Used in) Investing Activities 18.9M USD -27.9%
Common Stock, Shares Authorized 34.2M shares -85%
Common Stock, Shares, Issued 5.9M shares -94.1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.28M USD -72.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.5M USD -48.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 198M USD +7.29%
Deferred Tax Assets, Gross 199M USD +7.05%
Operating Lease, Liability 3.6M USD +5.88%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -47.5M USD +0.11%
Lessee, Operating Lease, Liability, to be Paid 3.07M USD -32.5%
Property, Plant and Equipment, Gross 2.43M USD -22.9%
Operating Lease, Liability, Current 1.25M USD +2.38%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.56M USD +2.84%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.51M USD +2.79%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 276K USD -54.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.56M USD +28.7%
Deferred Tax Assets, Operating Loss Carryforwards 91M USD +14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 1.5M USD -40%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 836K USD -30.2%
Share-based Payment Arrangement, Expense 6.44M USD +9.46%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%